Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Applied Therapeutics
Biotech
FDA scraps adcomm for Applied's rare disease drug
After pushing back the decision for Applied’s metabolic disorder drug, the FDA has decided a planned advisory committee meeting won’t be required.
James Waldron
Sep 18, 2024 8:00am
Applied Tx’s pediatric rare disease prosect hits another snag
Mar 29, 2024 10:21am
Applied claims victory in phase 3 SORD fight, plots path to FDA
Feb 15, 2024 10:10am
Scorpion taps new CEO, CMO—Chutes & Ladders
Jan 5, 2024 9:30am
Applied Therapeutics fails heart disease phase 3, seeks partner
Jan 5, 2024 8:03am
Applied fails phase 3 trial, plans to seek approval anyway
Apr 24, 2023 9:10am
